Introduction
20 mg
Recently, dexamethasone, a synthetic corticosteroid, was shown to decrease the mortality in COVID-19 patients who were on ventilators or oxygen therapy
Occasionally, CAP may progress to more severe pneumonia despite appropriate therapy
Dexamethasone is a corticoid substance used for a variety of indications, including diagnosing Cushing's disease [], as therapy for brain oedema [], and as adjunctive treatment in bacterial meningitis [] for more than 40 years
Their benefits far outweigh the risks, particularly in patients with severe forms of pneumonia
Dexamethasone an approved corticosteroid medication, acting as an anti-inflammatory and immunosuppressant agent
9% of patients in the dexamethasone arm died within 28 days after randomization versus 25
1 The data also indicated that dexamethasone might increase
6 mg/kg once a day for 2 days) is comparable to a 5-day course of prednisone/prednisolone in the treatment of acute asthma exacerbations
low potassium level - leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling; or
Dexamethasone 12 mg once, then 6 mg/day (either PO/IV)
Dexamethasone should be administered to all patients (AI)
The potential harmful adverse effects We postulated that dexamethasone treatment in hospitalized patients with COVID-19 pneumonia without additional oxygen requirements and at risk of progressing to severe disease might lead to a decrease in the development of ARDS and thereby reduce death